Published in Curr Dermatol Rep on February 09, 2014
Clinical benefit assessment of vismodegib therapy in patients with advanced basal cell carcinoma. Oncologist (2014) 0.92
New basal cell carcinoma susceptibility loci. Nat Commun (2015) 0.87
Advances in the management of basal cell carcinoma. F1000Prime Rep (2015) 0.85
Optimization of multimodal spectral imaging for assessment of resection margins during Mohs micrographic surgery for basal cell carcinoma. Biomed Opt Express (2014) 0.82
Sonidegib (Odomzo) for the Systemic Treatment of Adults With Recurrent, Locally Advanced Basal Cell Skin Cancer. P T (2016) 0.81
Nanoparticles and nanofibers for topical drug delivery. J Control Release (2015) 0.80
Metastatic basal cell carcinoma: a frequent disease with rare clinical evolution. BMJ Case Rep (2015) 0.79
Hedgehog pathway inhibition in advanced basal cell carcinoma: latest evidence and clinical usefulness. Ther Adv Med Oncol (2016) 0.78
Safety and Efficacy of Oral Polypodium leucotomos Extract in Healthy Adult Subjects. J Clin Aesthet Dermatol (2015) 0.78
Undermining plastic surgery as a possible option for treating basal cell carcinoma of the forehead. Wien Med Wochenschr (2017) 0.78
Basal Cell Carcinoma: A Comprehensive Review of Existing and Emerging Nonsurgical Therapies. J Clin Aesthet Dermatol (2016) 0.77
Noninvasive real-time characterization of non-melanoma skin cancers with handheld optoacoustic probes. Photoacoustics (2017) 0.75
Differential pharmacology and clinical utility of sonidegib in advanced basal cell carcinoma. Onco Targets Ther (2017) 0.75
Implementation of fluorescence confocal mosaicking microscopy by "early adopter" Mohs surgeons and dermatologists: recent progress. J Biomed Opt (2017) 0.75
A Prognostic Dilemma of Basal Cell Carcinoma with Intravascular Invasion. Plast Reconstr Surg Glob Open (2016) 0.75
Association of Shiny White Blotches and Strands With Nonpigmented Basal Cell Carcinoma: Evaluation of an Additional Dermoscopic Diagnostic Criterion. JAMA Dermatol (2016) 0.75
Basal Cell Carcinoma Surgery: Simple Undermining Approach in Two Patients with Different Tumour Locations. Open Access Maced J Med Sci (2017) 0.75
Large basal cell carcinoma of the scalp. Wien Med Wochenschr (2017) 0.75
Pigmented Paraaxillary Located "Complex" Basal Cell Carcinoma Imitating clinically irritated Melanocytic Lesion - Succesfull Surgical Approach in Bulgarian Patient. Open Access Maced J Med Sci (2017) 0.75
Skin Cancer Epidemics in the Elderly as An Emerging Issue in Geriatric Oncology. Aging Dis (2017) 0.75
The role of macrophages in skin homeostasis. Pflugers Arch (2017) 0.75
Cutaneous basal cell carcinoma with distant metastasis to thorax and bone : A clinicopathological and immunohistochemical study of 15 cases. Virchows Arch (2017) 0.75
The Hedgehog and Wnt signalling pathways in cancer. Nature (2001) 9.19
Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. Genes Dev (2002) 8.56
Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol (2010) 8.55
Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med (2009) 8.55
Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science (1996) 8.06
Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature (1998) 7.43
Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med (2012) 6.90
Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer (2008) 4.34
Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome. N Engl J Med (2012) 4.19
Basal cell carcinomas in mice overexpressing sonic hedgehog. Science (1997) 3.84
Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature. Br J Dermatol (2004) 2.63
Itraconazole and arsenic trioxide inhibit Hedgehog pathway activation and tumor growth associated with acquired resistance to smoothened antagonists. Cancer Cell (2013) 2.62
Tumor recurrence 5 years after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma. J Invest Dermatol (2012) 2.49
Identification of mutations in the human PATCHED gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome. J Invest Dermatol (1998) 2.00
Topical treatment of Basal cell carcinomas in nevoid Basal cell carcinoma syndrome with a smoothened inhibitor. J Invest Dermatol (2011) 1.98
Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. Br J Cancer (1997) 1.74
Advanced basal cell carcinoma. Wien Med Wochenschr (2013) 1.71
Genetic variants in pigmentation genes, pigmentary phenotypes, and risk of skin cancer in Caucasians. Int J Cancer (2009) 1.69
Metastatic basal cell carcinoma presenting with unilateral upper extremity edema and lymphatic spread. J Am Acad Dermatol (2008) 1.51
Surgical excision versus curettage plus cryosurgery in the treatment of basal cell carcinoma. Dermatol Surg (2007) 1.47
Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib. J Am Acad Dermatol (2013) 1.35
Teratogenic compounds of Veratrum californicum (Durand). V. Comparison of cyclopian effects of steroidal alkaloids from the plant and structurally related compounds from other sources. Teratology (1968) 1.27
Phase I study of the Hedgehog pathway inhibitor IPI-926 in adult patients with solid tumors. Clin Cancer Res (2013) 1.25
Hedgehog pathway inhibition and the race against tumor evolution. J Cell Biol (2012) 1.24
Basal cell carcinoma, squamous cell carcinoma and melanoma of the skin: analysis of the Singapore Cancer Registry data 1968-97. Br J Dermatol (2003) 1.11
Update on metastatic basal cell carcinoma: a summary of published cases from 1981 through 2011. JAMA Dermatol (2013) 1.06
Treatment of basal-cell carcinoma: comparison of radiotherapy and cryotherapy. Clin Radiol (1986) 1.05
Advanced basal cell carcinoma of the skin: targeting the hedgehog pathway. Curr Opin Oncol (2013) 0.97
Targeting the hedgehog pathway: the development of cyclopamine and the development of anti-cancer drugs targeting the hedgehog pathway. Mini Rev Med Chem (2011) 0.96
Hedgehog antagonist GDC-0449 is effective in the treatment of advanced basal cell carcinoma. Laryngoscope (2010) 0.91
Platinum-based cytotoxic therapy in basal cell carcinoma--a review of the literature. Acta Oncol (1996) 0.90
Utilities for advanced basal cell carcinoma. J Med Econ (2013) 0.90
Evasion of p53 and G2/M checkpoints are characteristic of Hh-driven basal cell carcinoma. Oncogene (2013) 0.89
Cisplatin-based chemotherapy in advanced basal and squamous cell carcinomas of the skin: results in 28 patients including 13 patients receiving multimodality therapy. J Clin Oncol (1990) 0.87
Surgical excision after neoadjuvant therapy with vismodegib for a locally advanced basal cell carcinoma and resistant basal carcinomas in Gorlin syndrome. JAMA Dermatol (2013) 0.87
Delayed treatment and continued growth of nonmelanoma skin cancer. J Am Acad Dermatol (2010) 0.86
The role of TP53 and MDM2 polymorphisms in TP53 mutagenesis and risk of non-melanoma skin cancer. Carcinogenesis (2010) 0.85
Metastatic basal cell carcinoma: complete response to chemotherapy and associated pure red cell aplasia. Cancer Invest (2006) 0.84
Markedly improved overall survival in 10 consecutive patients with metastatic basal cell carcinoma. Br J Dermatol (2013) 0.83
Rerecurrence 5 years after treatment of recurrent cutaneous basal cell and squamous cell carcinoma. JAMA Dermatol (2013) 0.82
Complete response of metastatic basal cell carcinoma to cisplatin chemotherapy: a report on two patients. Arch Dermatol (1990) 0.81
Preoperative treatment of advanced skin carcinoma with cisplatin and bleomycin. Am J Clin Oncol (1999) 0.81
Nonmelanoma skin cancer in young women. J Drugs Dermatol (2013) 0.80
Indoor ultraviolet tanning: what the data do and do not show regarding risk of melanoma and keratinocyte malignancies. J Natl Compr Canc Netw (2010) 0.80
Molecular signatures of basal cell carcinoma susceptibility and pathogenesis: a genomic approach. Int J Oncol (2012) 0.77
The impact of inoperable advanced basal cell carcinoma: the economic, physical, and psychological burden of the disease. J Drugs Dermatol (2013) 0.75